API Gallery
The global Mephenesin market is projected to experience steady growth between 2025 and 2035, with a CAGR of 5.6%. This growth is driven by the increasing prevalence of neurological and musculoskeletal disorders, along with the growing demand for muscle relaxants in postoperative care and spinal cord injury treatments.
The Mesterolone market is projected to grow at a CAGR of 5.1% from 2025 to 2035, fueled by increasing awareness and diagnosis of male hypogonadism and age-related testosterone deficiency.
The Fezolinetant market is witnessing a CAGR of 4.5% during the forecast period of 2025-2035. Fezolinetant, sold under the brand name VEOZAH, is a major leap in the management of moderate to severe vasomotor symptoms (VMS) of menopause. Astellas Pharma Inc.
The Fexuprazan market is witnessing a CAGR of 4.5% during the forecast period of 2025-2035. Fexuprazan is a new potassium-competitive acid blocker (P-CAB) that is a valuable advancement in the management of acid-related gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Helicobacter pylori infection.
The Fexofenadine market is witnessing a CAGR of 4.5% during the forecast period of 2025-2035. Fexofenadine, whose brand name is Allegra, is a second-generation antihistamine widely used to treat symptoms of allergic rhinitis and chronic urticaria.
The sodium lauryl sulfate market is experiencing a CAGR of 4.0% during the forecast period. Market growth is primarily driven by rising demand across personal care, household cleaning, and industrial sectors.
The Sodium Methylparaben market is experiencing a CAGR of 5.9% during the forecast period. This steady growth is driven by increasing applications of Sodium Methylparaben as a preservative in the pharmaceutical, cosmetic, and food industries, owing to its antimicrobial properties, stability, and cost-effectiveness.
Sodium Nitroprusside API market is experiencing a CAGR of 5.2% during the forecast period.
The global Alpha-D-Galactose market is projected to grow at a CAGR of 4.6% during the forecast period, driven by its increasing use in biochemical research, glycoprotein synthesis, and nutritional product development.
The global Azilsartan market is projected to grow at a CAGR of 5.1% during the forecast period, driven by its increasing use in the management of essential hypertension. Azilsartan is a highly selective angiotensin II receptor blocker (ARB) that inhibits vasoconstriction and aldosterone release, leading to improved blood pressure control and cardiovascular risk reduction.
The global Betamethasone Acetate market is projected to grow at a CAGR of 4.9% during the forecast period, driven by its wide use in the treatment of dermatological disorders, rheumatoid arthritis, and adrenal insufficiency.
Sodium Phenylbutyrate market is experiencing a CAGR of 10.3 % during the forecast period, This growth is driven by the increasing prevalence of urea cycle disorders (UCDs) and other rare metabolic diseases, where sodium phenylbutyrate plays a critical therapeutic role.
Sodium Picosulfate market is experiencing a CAGR of 5% during the forecast period.
The global Betamethasone Dipropionate market is projected to grow at a CAGR of 5.4% during the forecast period, driven by its widespread use in the treatment of chronic inflammatory skin disorders such as psoriasis, eczema, and seborrheic dermatitis.
Sodium Oxybate market is experiencing a CAGR of 8.5% during the forecast period, This growth is primarily driven by rising awareness of narcolepsy and other sleep disorders, alongside increasing prescriptions for sodium oxybate-based therapeutics such as Xyrem and Xywav.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
